Han Miyatake

Han Miyatake

Auto-generated profile, based on publicly available information

Han Miyatake

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
MMMasaaki Miyauchi
Masaaki Miyauchi
Masao ToyodaMasao Toyoda
Masao Toyoda
NKNoriko Kaneyama
Noriko Kaneyama
HMHan Miyatake
Han Miyatake
ETEitaro Tanaka
Eitaro Tanaka
MFMasafumi Fukagawa
Masafumi Fukagawa
We compared the efficacy of activity monitor (which displays exercise intensity and number of steps) versus that of pedometer in exercise therapy for patients with type 2 diabetes. The study subjects were divided into the activity monitor group (n=92) and pedometer group (n=95). The primary goal was improvement in hemoglobin A1c (HbA1c). The exercise target was set at 8,000 steps/day and 20 minutes of moderate-intensity exercise (≥3.5 metabolic equivalents). The activity monitor is equipped with a triple-axis accelerometer sensor capable of measuring medium-intensity walking duration, number of steps, walking distance, calorie consumption, and total calorie consumption. The pedometer counts the number of steps. Blood samples for laboratory tests were obtained during the visits. The first examination was conducted at the start of the study and repeated at 2 and 6 months. A significant difference in the decrease in HbA1c level was observed between the two groups at 2 months. The results suggest that the use of activity level monitor that displays information on exercise intensity, in addition to the number of steps, is useful in exercise therapy as it enhances the concept of exercise therapy and promotes lowering of HbA1c in diabetic patients.

17 February 2019 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
MKMoritsugu Kimura
Moritsugu Kimura
Masao ToyodaMasao Toyoda
Masao Toyoda
NSNobumichi Saito
Nobumichi Saito
NKNoriko Kaneyama
Noriko Kaneyama
HMHan Miyatake
Han Miyatake
MFMasafumi Fukagawa
Masafumi Fukagawa
Objective. Podocytes have highly differentiated functions and are extremely difficult to grow; thus, damage of podocytes is associated with glomerular dysfunction. Desquamated podocytes can be detected in urine of patients with severe renal impairment. Unlike the rapidly progressive glomerular damage in glomerulonephritis, only a few desquamated podocytes are usually detected in diabetic nephropathy (DN). It is not clear whether the low podocyte count in DN is due to limitation of the conventional method or true pathological feature. The aim of this study was to compare the conventional method with a newly modified method in detecting podocytes in morning urine samples of patients with DN. Materials and Methods. The study subjects were patients with type 2 diabetes. Urine samples from these patients were analyzed by the conventional method (Cytospin®) and the modified method (SurePath™). We determined the rate of detection of urinary podocytes and the number of detected cells. Results. The detection rate and podocyte count were significantly higher by the modified method than by the conventional method. The differences in the detection rates and numbers of podocytes were not significant between patients with normoalbuminuria and those with macroalbuminuria. However, they were significant in patients with microalbuminuria. The number of podocytes in the urine correlated significantly with the albumin-to-creatinine ratio, but not with the estimated glomerular filtration rate. Conclusions. The true number of urinary podocytes, as measured by the modified SurePath™-based method, in patients with DN is much higher than that estimated by the conventional method.

30 June 2020 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
MKMoritsugu Kimura
Moritsugu Kimura
Masao ToyodaMasao Toyoda
Masao Toyoda
NSNobumichi Saito
Nobumichi Saito
NKNoriko Kaneyama
Noriko Kaneyama
HMHan Miyatake
Han Miyatake
MFMasafumi Fukagawa
Masafumi Fukagawa
In the article titled “A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy” [1], the authors would like to clarify why the SurePath™ method was used in urine from diabetic nephropathy patients. The following text should be replaced with the addition of two missing references, 26 and 27 [2, 3]: